Literature DB >> 1440821

Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study.

C Ripert1, B Couprie, R Moyou, F Gaillard, M Appriou, J Tribouley-Duret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1440821     DOI： 10.1016/0035-9203(92)90247-a

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  5 in total

1.  Update on Hepatobiliary and Pulmonary Flukes.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

Review 2.  North American paragonimiasis (Caused by Paragonimus kellicotti) in the context of global paragonimiasis.

Authors:  Gary W Procop
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

3.  Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.

Authors:  J B Lecaillon; J Godbillon; J Campestrini; C Naquira; L Miranda; R Pacheco; R Mull; A A Poltera
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

4.  Endemicity of Paragonimus and paragonimiasis in Sub-Saharan Africa: A systematic review and mapping reveals stability of transmission in endemic foci for a multi-host parasite system.

Authors:  Muriel Rabone; Joris Wiethase; Paul F Clark; David Rollinson; Neil Cumberlidge; Aidan M Emery
Journal:  PLoS Negl Trop Dis       Date:  2021-02-05

Review 5.  Neglected tropical diseases: survey and geometry of randomised evidence.

Authors:  Shanthi Kappagoda; John P A Ioannidis
Journal:  BMJ       Date:  2012-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.